Ojjaara 100 mg/1
Momelotinib · TABLET · GlaxoSmithKline LLC
No Recall History
Plain English
Ojjaara is a tablet containing momelotinib at 100 mg/1, taken oral. Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- Ojjaara
- Generic Name
- Momelotinib
- NDC Code (Product)
81864-103- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 100 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA216873
- Marketing Start
- 09/15/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Ojjaara used for?
Ojjaara contains Momelotinib. It is a tablet taken oral. Consult your doctor for specific uses.
Is Ojjaara a controlled substance?
Ojjaara is not classified as a controlled substance by the DEA.
What is the generic name for Ojjaara?
The generic name for Ojjaara is Momelotinib. There are no other listed brand versions of Momelotinib.
What is the NDC code for Ojjaara 100 mg/1?
The NDC (National Drug Code) for Ojjaara 100 mg/1 is 81864-103, listed by GlaxoSmithKline LLC.
Other Ojjaara Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)